Nathan Pennell, Senior Vice President and Worldwide Head of Hematology Oncology Medical Affairs at Bristol Myers Squibb, shared a post on LinkedIn by Bristol Myers Squibb, adding:
“Rocky’s story is a powerful reminder of the incredible dedication and spirit of the members of the myelodysplastic syndromes (MDS) community, from researchers and clinicians to the patients whose experiences help us understand this disease.
In my first months at Bristol Myers Squibb, I’ve been inspired by the commitment that drives discoveries and insights, all of which play a critical role in addressing the needs of the MDS community.
Thank you to everyone advancing innovation in MDS for your relentless pursuit of scientific progress and your commitment to improving outcomes for patients around the world.”
Quoting Bristol Myers Squibb‘s post:
“Rocky, an avid outdoorsman, faced significant health challenges for nearly two years before receiving a diagnosis of myelodysplastic syndromes (MDS), a group of rare blood cancers. His journey is one of many that drive the work we do.
Today on MDS Awareness Day, we reaffirm our commitment to advancing research, raising awareness, and providing resources to those affected by MDS, just like Rocky.
Learn more about MDS through Rocky’s inspiring survivorship journey on Survivorship Today.”
Proceed to the video attached to the post.
More posts featuring Nathan Pennell on OncoDaily.